Due to the rapidly changing nature of the COVID-19 pandemic, we at Univadis would like to share with you the most impactful and clinically relevant articles across our network from the past week.
Some of these articles are only published in local languages, but we have tried to summarize the key points for you below and link to the original source of each article in case you would like to read more, with languages other than English noted in brackets.
This is a snapshot of emerging best-practices during a rapidly evolving pandemic. Any and all information currently available related to COVID-19 is subject to change as more details become available. Some of the information below may also be contradicted by local or global health authorities. You can find all of the most up-to-date COVID-19 coverage on your local Univadis site or smartphone application.
We hope this information will be useful to your ongoing medical care for all patients, whether directly involved with COVID-19 or not.
- Given the scale of the pandemic, post-COVID-19 fibrosis could become a major public health problem. Clarifying quickly whether those who survive the disease develop pulmonary fibrosis would allow for adequate care and design interventions to prevent a second wave of mortality associated with this pandemic.
- The head of the Beijing Municipal Science and Technology Commission, Xu Qiang, reported that Beijing has organised 21 science and technology projects in response to the COVID-19 pandemic, including three vaccines in Phase 2 of clinical trials.
- Recent published work by French and German researchers suggests that hematopoietic stem cells have an immune memory, a finding that has ignited new interest in research against SARS-CoV-2 infection.
- Public Health France issued an epidemiological update [French] on May 14 announcing 65,000 healthcare professionals to be affected by COVID-19 in France, with nurses and caregivers on top of the list.
- Mathematical modelling to estimate the effectiveness of various social distancing forums in Germany showed that the spread of COVID-19 was reduced in three stages through measures of social distancing. In order to keep the reproduction rate below 1, however, the contact ban was needed.
- IQWiG and Cochrane Germany called on the EMA to publish clinical trial reports on all medicinal products and vaccines against COVID-19 in full and on the same day as the market approval.
- German researchers have created an algorithm based on three laboratory parameters from urine that can assess the risk of COVID-19 associated nephritis.
- In a new effort to increase prevention methods and return Spain to normality, the Spanish government established the use of a mandatory mask for those over 6 years old starting May 21st.
- In Milan, Italy, an analysis conducted on healthy blood donors provided new insights on the spread of the virus in the city and in the province. Main findings included that the virus was already circulating in Milan at the time of the outbreak in Lombardy (February 24, 2020). It also revealed that on April 8, 4.4-10.8% of healthy adults showed signs of seroconversion; and social distancing measures seem to have had a greater effect among young people.